Clinical trial · Observational
Factors Affecting Patient Participation in AIDS Malignancy Clinical Trials Consortium Clinical Trials
Improving Participation in AMC Clinical Trials (IMPACTS)
NCT01946217CI-TRIAL-00023545completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This pilot research trial studies factors affecting patient participation in Acquired Immune Deficiency Syndrome (AIDS) Malignancy Clinical Trials Consortium clinical trials. Determining how patients makes decisions about participating in a clinical trial may help doctors plan clinical trials in which more patients are willing to participate and are satisfied with their decision to participate.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| HIV Infection | — | UNRESOLVED | — |
| Malignant Neoplasm | Malignant Neoplasm | ONTOLOGY_EXACT | 0.90 |
| Precancerous Condition | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| questionnaire administration | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Observational (questionnaire administration)
- description
- Participants complete the IMPACTS survey comprising questions about socio-demographic information and clinical trial participation.
- interventionNames
- Other: questionnaire administration
Primary outcomes (1)
- measure
- Participant level factors affecting recruitment of potentially eligible participants in AMC intervention studies
- timeFrame
- Up to 2 weeks
- description
- The proportion of individuals who are screened and agree to enroll in a clinical trial will be estimated with the binomial proportion and its 95% confidence interval.
Secondary outcomes (4)
- measure
- Socio-demographic characteristics for participation and non-participation in AMC clinical trials among all approached volunteers across AMC sites
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * HIV-infected participants * Cancer or anal dysplasia diagnosis * Offered informed consent on an AMC interventional clinical trial * Ability to understand and the willingness to sign a written informed consent document Exclusion Criteria: * Inability to provide informed consent
References
Publications (0)
Data not yet available
No reference posted for this study.